13:16:15 EDT Fri 30 Sep 2022
Enter Symbol
or Name
USA
CA



MYM Nutraceuticals Inc
Symbol MYM
Shares Issued 54,046,429
Close 2017-06-15 C$ 0.26
Recent Sedar Documents

MYM Nutraceuticals receives DTC approval

2017-06-16 13:05 ET - News Release

Mr. Rob Gietl reports

MYM NUTRACEUTICALS INC. RECEIVES DTC APPROVAL, ALLOWING US INVESTORS TO TRADE SHARES UNDER THE SYMBOL MYMMF

MYM Nutraceuticals Inc. has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol MYMMF.

This approval opens MYM up to the most important and influential investment market on the planet. Current U.S. law has prevented American cannabis companies from going public, making it very difficult for Americans to invest in the rapidly expanding multibillion-dollar cannabis industry. Due to its progressive cannabis laws, Canada has become the Mecca for cannabis investment worldwide. MYM not only has a foothold in Canada but is expanding into the U.S. and internationally to build a global brand.

"We are very pleased to be trading on the U.S. market as it will provide our American investors with timely news and information to help them better analyze, value and trade our securities," said Rob Gietl, chief executive officer of MYM. "Without a U.S. symbol, it is difficult for Americans to buy shares in a Canadian company. This removes that barrier and is very timely for MYM as we are currently in talks with several U.S. companies in the cannabis space."

MYM shares trade in Canada, Germany and the U.S. under the following symbols: Canadian Securities Exchange -- MYM, OTC -- MYMMF, Frankfurt Stock Exchange -- 0MY, Deutsche Borse -- 0MY, Munich Stock Exchange -- 0MY and Stuttgart Stock Exchange -- 0MY.

MYM is continuing to negotiate acquisitions of complementary businesses and assets in the technology, nutraceuticals and cannabidiol sector, and is currently in talks with other innovative companies to ensure a strong presence and growth potential within the industry.

About MYM Nutraceuticals Inc.

MYM's primary focus is developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.